Page last updated: 2024-10-27

fenofibrate and Cushing Syndrome

fenofibrate has been researched along with Cushing Syndrome in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meikle, AW1
Findling, J1
Kushnir, MM1
Rockwood, AL1
Nelson, GJ1
Terry, AH1

Other Studies

1 other study available for fenofibrate and Cushing Syndrome

ArticleYear
Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: Adult; Chromatography, High Pressure Liquid; Cushing Syndrome; Diagnosis, Differential; Female; Feno

2003